CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Impacts of Subtype on Clinical Feature and Outcome of Male Breast Cancer: Multicenter Study in Korea (KCSG BR16-09)
Jieun Lee, Keun Seok Lee, Sung Hoon Sim, Heejung Chae, Joohyuk Sohn, Gun Min Kim, Kyung-Hee Lee, Su Hwan Kang, Kyung Hae Jung, Jae-ho Jeong, Jae Ho Byun, Su-Jin Koh, Kyoung Eun Lee, Seungtaek Lim, Hee Jun Kim, Hye Sung Won, Hyung Soon Park, Guk Jin Lee, Soojung Hong, Sun Kyung Baek, Soon Il Lee, Moon Young Choi, In Sook Woo
Cancer Research and Treatment. 2023;55(1):123-135.   Published online 2022 March 24    DOI: https://doi.org/10.4143/crt.2021.1561

Excel Download

Impacts of Subtype on Clinical Feature and Outcome of Male Breast Cancer: Multicenter Study in Korea (KCSG BR16-09)
Cancer Research and Treatment. 2023;55(1):123-135   Crossref logo
Link1 Link2 Link3

Exemestane as Adjuvant Treatment of Early Breast Cancer: Intergroup Exemestane Study/Tamoxifen Exemestane Adjuvant Multicenter Trials
Clinical Breast Cancer. 2006;6:S41-S44   Crossref logo
Link1 Link2

Male Breast Cancer According to Tumor Subtype and Race: A Population-Based Study
Breast Diseases: A Year Book Quarterly. 2013;24(4):327-328   Crossref logo
Link1 Link2

Male breast cancer according to tumor subtype and race
Cancer. 2013;119(9):1611-1617   Crossref logo
Link1 Link2

The prognostic significance of molecular subtype for male breast cancer: A 10-year retrospective study
The Breast. 2013;22(5):824-827   Crossref logo
Link1 Link2

Immunohistochemical subtypes and clinical outcome correlation of male breast cancer
Pathology. 2014;46:S110   Crossref logo
Link1 Link2

Exosomal Del-1 as a Potent Diagnostic Marker for Breast Cancer: Prospective Cohort Study
Clinical Breast Cancer. 2021;21(6):e748-e756   Crossref logo
Link1 Link2

Exploratory biomarker analysis from a phase II clinical trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine for HER2-negative metastatic breast cancer patients (KCSG BR13-11)
Breast Cancer Research and Treatment. 2019;178(2):367-377   Crossref logo
Link1 Link2 Link3

Outcome of Male Breast Cancer: A Matched Single-Institution Series
Clinical Breast Cancer. 2014;14(5):371-377   Crossref logo
Link1 Link2

A Novel Combined Approach for Metastatic Breast Cancer with Dural and Leptomeningeal Disease with an Impressive Clinical Outcome: A Case Study
Journal of Cancer Therapy. 2018;09(03):274-280   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.